Physician
Allergy & Immunology
Dr. Lynn E. Spitler, MD
|
|
Give Review
Lynn E. Spitler practices Allergy & Immunology. She studied medicine at University of Michigan Medical School. She over the years received 1 awards: "Regional Top Doctor". Lynn Spitler is also a published doctor. She has 99 publication published. The most recent publication is: The effect of levamisole on cellular immunity in multiple sclerosis. Lynn E. Spitler accepts Medicare.
Publications
- Phase II study of nab-paclitaxel and bevacizumab as first-line therapy for patients with unresectable stage III and IV melanoma.
- Biological Effects of Anti-Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Antibody Formation in Patients Treated With GM-CSF (Sargramostim) as Adjuvant Ther...
- Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF, sargramostim) administered for 3 years as adjuvant therapy of stages II(T4), III, and IV me...
- Low-dose outpatient chemobiotherapy with temozolomide, granulocyte-macrophage colony stimulating factor, interferon-alpha2b, and recombinant interleukin-2 for the trea...
- Adjuvant therapy of melanoma.
- Noninterferon-based adjuvant therapy for high-risk melanoma.
- A phase 1 study of granulocyte macrophage colony-stimulating factor (sargramostim) and escalating doses of thalidomide in patients with high-risk malignant melanoma.
- Clinical uses of transfer factor.
- Short-term autologous tumor cell lines for the active specific immunotherapy of patients with metastatic melanoma.
- Adjuvant therapy of melanoma: at what cost?
- Clinical experience with autologous tumor cell lines for patient-specific vaccine therapy in metastatic melanoma.
- Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor.
- Generation of PSA-reactive effector cells after vaccination with a PSA-based vaccine in patients with prostate cancer.
- Oil-in-water liposomal emulsions: characterization and potential use in vaccine delivery.
- Immunologic approaches to the treatment of prostate cancer.
- Cancer vaccines: the interferon analogy.
- Immunologic mechanisms in multiple sclerosis. Exacerbation by type A hepatitis and skin test antigens.
- Nephropathy in the Wiskott-Aldrich syndrome.
- Transfer factor: failure to transfer reactivity in normal human subjects.
- Serum copper and zinc levels in melanoma patients.
- Transfer factor therapy for histoplasmosis in a patient with Hodgkin's disease.
- Experimental allergic encephalitis; treatment with drugs which alter CNS serotonin levels.
- Treatment of Behcet's syndrome with levamisole.
- A randomized trial of levamisole versus placebo as adjuvant therapy in malignant melanoma.
- BCG, levamisole and transfer factor in the treatment of cancer.
- Adjuvant immunotherapy with transfer factor in patients with melanoma metastatic to lung.
- Penetration of anti-melanoma immunotoxin into multicellular tumor spheroids and cell kill effects.
- Preliminary studies on human "transfer factor" activity in guinea pigs. Systemic transfer of cutaneous delayed-type hypersensitivity to PPD and SKSD.
- Effects of levamisole on in vivo and in vitro murine host response to syngeneic transplantable tumor.
- Phagocytes and C4 in paraproteinaemia.
- The Wiskott-Aldrich syndrome. Immunologic studies in nine patients and selected family members.
- Transfer factor II: results of therapy.
- Leukocyte migration inhibition in agarose.
- Cellular immune response in coccidioidomycosis.
- Coexistent lymphoid interstitial pneumonia, pernicious anemia, and agammaglobulinemia.
- Transfer factor I: methods of therapy.
- Osteogenic sarcoma. Immunologic parameters before and during immunotherapy with tumor-specific transfer factor.
- The effect of levamisole on cellular immunity in multiple sclerosis.
- Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis.
- Levamisole.
- Combined immunotherapy in malignant melanoma. Regression of metastatic lesions in two patients concordant in timing with systemic administration of transfer factor and...
- [Resistance deficiency in multiple myeloma].
- Combined immunotherapy of malignant melanoma. Unusual survival following cerebral metastasis.
- Disseminated Cryptococcus treated with transfer factor.
- Cellular immune reactivity in patients with rheumatoid arthritis and effects of levamisole.
- Treatment of Bechçet's syndrome with transfer factor.
- Improved immune-specificity in monoclonal radioimmunoimaging using dual radionuclide color functional maps.
- Phase 1 immunolymphoscintigraphy with an In-111-labeled antimelanoma monoclonal antibody.
- Immunotoxin therapy of malignant melanoma.
- Humoral immune response to a ricin A chain immunotoxin in patients with metastatic melanoma.
- Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin.
- Toxicity and immunogenicity of monoclonal antimelanoma antibody-ricin A chain immunotoxin in rats.
- Phase I study of a murine monoclonal anti-lipid A antibody in bacteremic and nonbacteremic patients.
- Clinical trials of transfer factor in malignancy.
- A randomized, double-blind, placebo-controlled trial of transfer factor as adjuvant therapy for malignant melanoma.
- Clinical studies: solid tumors.
- Therapy of metastatic malignant melanoma using Xomazyme Mel, a murine monoclonal anti-melanoma ricin A chain immunotoxin.
- Antimelanoma monoclonal antibody-ricin A chain immunoconjugate (XMMME-001-RTA) plus cyclophosphamide in the treatment of metastatic malignant melanoma: results of a ph...
- Human antibody responses to components of the monoclonal antimelanoma antibody ricin A chain immunotoxin XomaZyme-MEL.
- The effects of cyclophosphamide on the toxicity and immunogenicity of ricin A chain immunotoxin in rats.
- Monoclonal antibodies in the treatment of malignant melanoma.
- Transfer factor therapy in the Wiskott-Aldrich syndrome. Results of long-term follow-up in 32 patients.
- International symposium on levamisole in rheumatoid arthritis. A review of short and longterm effects on articular manifestations.
- Effect of levamisole as a surgical adjuvant therapy for malignant melanoma.
- Transfer factor.
- Altered regulation of mitogen responsiveness by suppressor cells in multiple sclerosis.
- Recurrent aphthous stomatitis: current status of etiology and treatment.
- Immunotherapy in infectious disease, autoimmunity and cancer.
- Immunotherapy of melanoma with BCG: two fatalities following intralesional injection.
- Transfer factor therapy in ataxia--telangiectasia.
- Renal lesions accompanying poison oak dermatitis.
- Transfer factor in immunodeficiency diseases.
- Experimental allergic encephalitis: study of cellular immunity during disease suppression.
- Leukocyte-migration inhibition in guinea pigs. I. Correlation with skin test reactivity and macrophage-migration inhibition.
- Experimental allergic encephalitis: study of cellular immunity to the encephalitogenic determinant.
- Myelopathy after duck embryo rabies vaccine.
- Letter: Transfer factor.
- Comparison of experimental allergic encephalomyelitis induced with spinal cord, basic protein, and synthetic encephalitogenic peptide.
- Letter: The use of the cell migration inhibition test.
- Treatment of mucocutaneous candidasis with transfer factor.
- Transfer factor therapy in immune deficiency states.
- Treatment of immune deficiency.
- Rosette-forming cells, immunologic deficiency diseases and transfer factor.
- Blocking of a cellular immune reaction to malignant melanoma by immunoglobulin from tumor-bearing animals.
- The Wiskott-Aldrich syndrome. Results of transfer factor therapy.
- Agammaglobulinemia, absent delayed sensitivity and lymphopenia without infections. A demonstration of immunologic unknowns.
- In vitro demonstration of delayed hypersensitivity in patients with berylliosis.
- [Transfer factor. Immunologic basis and therapeutic experience].
- Experimental allergic encephalitis. Dissociation of cellular immunity to brain protein and disease production.
- Demonstration of cellular immunity to tumor-specific antigens of malignant melanoma in hamsters by inhibition of macrophage migration.
- Studies of lymphocyte culture: products of sensitive lymphocyte-antigen interaction.
- Wiskott-Aldrich syndrome, a genetically determined cellular immunologic deficiency: clinical and laboratory responses to therapy with transfer factor.
- Products of interaction of antigen-sensitized leukocytes and antigen: further characterization of the mitogenic factor.
- Zoster immune globulin.
- Lymphocytotoxic antibody in multiple sclerosis: activity against T cell subsets and correlation with disease activity.
- Purification of monoclonal antibodies from mouse ascites eliminates contaminating infectious mouse type C viruses and nucleic acids.
- Inhibition of capillary migration by antigen-antibody complexes.
- Mycoplasma inhibition of phytohemagglutinin stimulation of lymphocytes.
Schools
University Of Michigan Medical School
Highland Alameda Co Hospital
Uc San Francisco Med Center
New York University Med Center
Procedures Preformed
- Bone Marrow Aspiration
Doctors Specialties
- Internal Medicine
- Allergy
- Immunology
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
UCSF -
Alameda County Medical Center -
University of Michigan Medical School
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1588867535 |
| Last Name Of The Provider | SPITLER |
| First Name Of The Provider | LYNN |
| View All |
Similar Doctors
|
Dr. Roger F. Espiritu, MD |
|
|
Dr. Jeffrey M. Davidson, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kandice K. Strako, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Faith R. Bocobo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arpana R. Vidyarthi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rupali Das, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Walford J. Fessel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Calvin S. So, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory J. Burrell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer R. Staves, MD |
|
|
Dr. Joshua M. Veith, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lekshmi Santhosh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thao H. Tran, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Robert Deitz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Calvin S. So
This Doctor is OpenDoctor Recommended.
|